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Golgi anti-apoptotic protein (GAAP), also known as transmembrane Bax
inhibitor-1 motif-containing 4 (TMBIM4) or Lifeguard 4 (Lfg4), shares remark-
able amino acid conservation with orthologues throughout eukaryotes,
prokaryotes and some orthopoxviruses, suggesting a highly conserved
function. GAAPs regulate Ca2þ levels and fluxes from the Golgi and endoplas-
mic reticulum, confer resistance to a broad range of apoptotic stimuli, promote
cell adhesion andmigration via the activation of store-operated Ca2þ entry, are
essential for the viability of human cells, and affect orthopoxvirus virulence.
GAAPs are oligomeric, multi-transmembrane proteins that are resident in
Golgi membranes and form cation-selective ion channels that may explain
the multiple functions of these proteins. Residues contributing to the ion-
conducting pore have been defined and provide the first clues about the
mechanistic link between these very different functions of GAAP. Although
GAAPs are naturally oligomeric, they can also function asmonomers, a feature
that distinguishes them from other virus-encoded ion channels that must oli-
gomerize for function. This review summarizes the known functions of
GAAPs and discusses their potential importance in disease.
1. Introduction: the transmembrane BI-1-containing
motif/Lifeguard family and the ancestral GAAP
1.1. Discovery and origins of GAAPs
In 2002, sequencing of the camelpox virus (CMLV) genome identified a novel
gene, 6L, located in the left terminal region of the genome [1]. This gene encodes
a highly hydrophobic, 237 amino acid (aa), membrane protein of approximately
23 kDa that was characterized and named Golgi anti-apoptotic protein (GAAP)
based on its intracellular localization and its first described function [2]. Bio-
informatic analysis identified GAAP relatives in some other orthopoxviruses,
including some strains of vaccinia virus (VACV) [1], the vaccine used to eradicate
smallpox, but also throughout higher eukaryotes, as well as some sponges, fungi,
yeast and an increasing number of prokaryotes [2–5]. Similarly, a human ortho-
logue of unknown function was identified from the human genome sequencing
project, and was expressed and characterized [2].
Since the discovery of GAAPs, the viral and human versions (vGAAP and
hGAAP, respectively) have been the most studied, leading to the identification of
several cellular functions and structural properties of GAAPs. Both vGAAP and
hGAAP localize to the Golgi apparatus [2] and confer resistance to a broad range
of pro-apoptotic stimuli of both intrinsic and extrinsic origins [2,4]. Human
GAAP regulates the Ca2þ content and fluxes from the principal intracellular Ca2þ
stores (Golgi and endoplasmic reticulum, ER) [6] and promotes cell adhesion
and migration via the activation of store-operated Ca2þ entry (SOCE) from the
extracellular space [7]. GAAPs are multi-transmembrane proteins that are also
& 2017 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.
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known to homo-oligomerize, and vGAAPs from VACV and
CMLV were shown to form cation-selective ion channels,
potentially forming the basis for the modulation of its diverse
functions [4,8].
1.2. Human GAAP: a housekeeping gene essential for
cell survival
hGAAP mRNA is expressed ubiquitously across all human
tissues tested, with lower expression detected in the brain com-
pared to other tissues [2,9,10]. The conservation of GAAP
expression suggested that its function may be fundamental to
the function of a wide variety of cell types. Indeed, hGAAP
wasproposed to be an essential, universal, housekeepingprotein
based onmicroarray analyses [11], and knockdown of endogen-
ous hGAAP by small interfering RNA (siRNA) demonstrated
that it is essential for cell viability because cells die by apoptosis
in its absence [2]. Interestingly, the viral protein is sufficiently
similar (73% aa identity) to complement for loss of hGAAP
in human cells. The requirement of other GAAP relatives in
simpler systems such as yeast or bacteria remains to be assessed
but may provide interesting information on the importance and
conservation of its essential housekeeping functions.
1.3. Why do some orthopoxviruses express a
viral GAAP?
ViralGAAPsare expressedbyCMLV, a fewstrainsofVACVand
cowpox virus, and are non-essential for viral replication [2].
However, it affects virus infection in vivo and deletion of
vGAAP from VACV strain Evans caused an increase in virus
virulence in vivo accompanied byan increased infiltration of leu-
cocytes into infected tissue [2]. Given that mammalian cells
express a GAAP, why have some orthopoxviruses evolved to
express a vGAAP? Possible explanations are (i) that the viral
protein has subtly different properties to the cellular protein
and these are advantageous to the virus, (ii) that the induction
of cell motility by vGAAP is beneficial to virus spread,
(iii) that vGAAP regulates the host response to infection, and
(iv) that the level of expression of cellular GAAP inmammalian
cells is low, and so expression at higher levels, as observed
during virus infection [2], is beneficial. The low level of cellular
GAAP expression will be reduced further during infection
because orthopoxviruses like VACV induce a rapid shut off of
cellular protein synthesis [12] mediated by the de-capping
enzymes D9 and D10 [13–15] and protein 169 [16]. Therefore,
the expression of vGAAP may help keep the infected cells
more suitable hosts to support virus replication. However,
under the cell culture conditions tested, a VACV engineered to
not express vGAAP replicated aswell as control viruses expres-
sing vGAAP [2]. Given that loss of vGAAP from VACV strain
Evans affects virus virulence and the influx of inflammatory
cells into infected tissue [2], vGAAP can be added to the long
list of immuno-regulators expressed by VACV that affect the
host response to infection [17].
1.4. GAAPs within the TMBIM and Lifeguard family: an
evolutionary perspective
Initially, GAAP was classified as the fourth member of the
transmembrane Bax (Bcl-2-associated X protein) inhibitor-1
motif-containing (TMBIM) family, based on similarities in the
number of predicted transmembrane domains (6–7 TMDs),
known as the UPF0005 motif, and a shared anti-apoptotic
function with the most studied member of the family, Bax
inhibitor-1 (BI-1), from which the family name was derived
[18–20]. Currently, this family includes seven well-conserved
members: responsive to centrifugal force and shear stress
gene 1 protein (RECS1) (TMBIM1), TMBIM1b, FAS inhibitory
molecule 2 (FAIM2)/LFG (TMBIM2), glutamate receptor
ionotropic NMDA-associated protein (GRINA) (TMBIM3),
GAAP (TMBIM4), growth hormone-inducible transmembrane
protein (Ghitm) (TMBIM5) and BI-1 (TMBIM6) [2,20–22].
Although the TMBIM family has been the most commonly
used classification, a subsequent phylogenetic analysis
showed that five of itsmembers, includingGAAP, cluster inde-
pendently of the Bax-motif-containing proteins, Ghitm and
BI-1, as far back as the root of all animals and possibly extant
eukaryotes, thus creating a diverging family nomenclature
known as the Lifeguard (LFG) family [5,21]. Current LFG
family members are therefore GRINA (Lfg1), FAIM2/LFG
(Lfg2), RECS1 (Lfg3), GAAP (Lfg4) and TMBIM1b (Lfg5).
GAAP contains key sequence similarities and differences of
functional consequence with both LFG and BI-1 families. For
instance, the SPE[ED]Ymotif between TMD6 and hydrophobic
loop 7 of GAAP, which is central within the channel pore and
important for cell adhesion andmigratory functions, is present
throughout the LFG family members but absent from Ghitm
and BI-1 [4,5,21]. Conversely, a series of charged residues at
the C terminus of GAAP (LEAVNKK) is conserved only in
BI-1 (EKDKKKEKK), Ghitm (RKK) and to a minimal extent
GRINA (KE) [4], with similar critical requirements for GAAP
and BI-1 in regulating cell adhesion, apoptosis and Ca2þ
homeostasis [3,7,23–25]. Furthermore, the most closely related
members to GAAPs are LFG protein and BI-1 with 34 and 28%
aa identity, respectively [2]. Despite the fact that the relation-
ship between these proteins is unclear, it is evident that a
divergence exists within the TMBIM family. If this separation
is as ancient as proposed, the LFG family would constitute
an independent family fromGhitm and BI-1, rather than a sub-
class of the TMBIM family. Nevertheless, phylogenetic analysis
from both classification systems indicate the most probable
family progenitor to have been a GAAP-like ancestor that
expanded by a series of duplication and subsequent modifi-
cation events to generate the current TMBIM and LFG family
members [5,19,21]. This could explain why GAAP and BI-1
share some properties, such as the charged C terminus, that
is absent in some other family members. More specifically,
expansion of the five LFG family members from a GAAP-like
progenitor was dated by phylogenetic analysis as prior to the
divergence of plants and protozoa about 2000 million years
ago [5,21].
TMBIM and LFG family members lack clear functional
motifs indicative of function [4,21], and therefore family mem-
bers have been studied independently, and findings from one
member have often been tested and applied in the study of
othermembers. Given the high degree of conservation between
these proteins, this exercise has been productive, highlighting
many similarities as well as functional variations (table 1).
Subsequent studies were aimed at reassembling the known
functions of TMBIM/LFG family members [18,19,21,67,68].
Indeed, a recent review proposed a global ‘stress integrator’
or ‘sentinel’ role for the family, thus regulating multiple
essential adaptive responses to global stresses caused
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by environmental changes across different interconnected
signalling pathways and tissues [18].
The strong conservation of hydrophobicity profile within
TMBIM and LFG members suggests that structure and/or
hydrophobicity must be a critical aspect of their function
[3,19]. This fits with the hypothesis that the ion channel
activity of GAAP and BI-1 constitutes the core function
from which their other functions are derived as downstream
target effects.
1.5. Why is GAAP highly conserved?
Orthologues of GAAP, identified throughout eukaryotes
and recently in some prokaryotes, are characterized by a
unique degree of protein sequence identity and length, with
the majority of proteins differing by only 1–4 aa in length,
and a strikingly conserved hydrophobicity profile maintained
right down to bacteria (figure 1), suggesting an important
fundamental cellular function, for which transmembrane
structure is necessary [2,4]. Unlike in mammals, vGAAP is
not ubiquitous among viruses and is found only in a subset
of orthopoxviruses that include 3 of 16 strains of VACV
examined, CMLV and cowpox virus [2,4]. In these viruses,
the vGAAPs differ in only a few aa from one another and
share more than 98% aa identity, and therefore also share the
conserved membrane structure (figure 1) [4]. The level of con-
servation in aa length (1 aa difference), identity (73%)
and hydrophobicity profile between vGAAPs and hGAAP is
greater than many other VACV proteins that have a known
mammalian orthologue [2]. For comparison, VACV strainWes-
tern Reserve proteins B15 [69] and B8 [70] share only 33% and
25% aa identity with the extracellular domain of the human
interleukin-1b receptor and interferon-g receptor, respectively.
Themuch closer similarity of vGAAPandmammalian GAAPs
might reflect a more recent acquisition of the host gene by
an ancestral poxvirus, or conservation of GAAP sequence
due to functional requirements. In this regard, the analysis of
the nucleotide composition of the viral and mammalian
GAAPs is informative. Orthopoxviruses such as VACV,
cowpox virus and CMVL have genomes with high AþT con-
tent (67% for VACV) that differ considerably from that of
humans and other mammalian genomes, and consequently
the codon usage of these viruses also differs from their mam-
malian hosts [1,71]. But the AþT content of vGAAP from
VACV (57.6%) or CMLV (59.0%) is more similar to hGAAP
(57.5%) than it is to the majority of the virus genome (67%).
So it has not yet adapted to the nucleotide composition of the
virus genome as a whole, either due to relatively recent gene
VACV Evans
GAAP orthologues
hGAAP
vGAAP CMLV
Ca. Chloracidobacterium thermophilum GAAP
aa identity (%) aa length
CPXV
CMLV
GAAP N
1 2 3 4 5 6 loop
C
–1
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residue
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Figure 1. Conservation within the GAAPs. The extent of hydrophobicity and sequence conservation among GAAP orthologues. (a) The aa identities calculated by the
BLASTP server and differences in aa length are indicated. (b) The hydrophobicity profile for hGAAP (eukaryote) was aligned with that of viral (vGAAP from CMLV)
and prokaryotic (Ca. Chloracidobacterium thermophilum) GAAP representatives. Complete aa sequences were used for all. (c) aa sequence alignment of hGAAP against
GAAP orthologues from two to three representative members from each taxon. The level of conservation for each residue was scored according to Scorecons and
represented in a colour gradient, with red and white indicating identity and no similarity, respectively. Sequences analysed include Homo sapiens, Bos taurus and
Gallus gallus (vertebrates); VACV Evans, CMLV and CPXV (viruses); Cerapachys biroi and Tribolium castaneum (insects); Penicillium chrysogenum and Tuber melanos-
porum ( fungi); Arabidopsis thaliana, Genlisea aurea and Zea mays ( plants); Schizosaccharomyces pombe and Saccharomyces cerevisiae (yeast); and Campylobacter
jejuni, Helicobacter pylori and Candidatus Chloracidobacterium thermophilum (bacteria). Black and grey boxes indicate the location of TMDs 1–6 and the hydrophobic
region/loop 7 of GAAPs, respectively. Adapted from Carrara et al. [4].
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acquisition or due to functional constraints. The ability of
VACV GAAP to restore cell viability following siRNA knock
down of the essential endogenous hGAAP demonstrates that
this conservation has retained protein function [2].
The high degree of conservation between GAAPs extends
beyond other poxviruses and mammals to distant eukaryotes
and even prokaryotes (figure 1). For instance, hGAAP shares
38% aa identity and 3 aa difference in length with GAAPs
from Arabidopsis thaliana [2], and vGAAP is quite conserved
with bacterial GAAPs including Candidatus Chloracidobacter-
ium thermophilum and Campylobacter jejuni (30.5% or 27.7%
aa identity, and only 2 or 6 aa difference in length, respect-
ively), as well as a fungal GAAP in Penicillium chrysogenum
(34.4% aa identity) [4]. This conservation is also strictly main-
tained in the hydrophobicity profiles of these GAAPs [4].
This remarkable conservation for such distantly related
organisms supports a highly conserved ancestral structure
and function [4]. Although GAAPs have not been reported
so far in archaea, the extensive list of orthologues is expected
to expand with the availability of newly sequenced genomes,
particularly among prokaryotes. Considering that structure
and activity of ion channels have evolved in prokaryotes
long before the emergence of complex multicellular organ-
isms [72], these novel and largely uncharacterized bacterial
GAAPs merit study and may provide a simpler system,
away from the complexities of inter-compartmentalized
Ca2þ fluxes of organelles, from which to dissect GAAP core
ion channel activity. Given the essential fundamental func-
tions and ancestral origins of GAAP, testing the extent of
conservation of its other functions down the evolutionary
tree could provide answers to other fundamental and essen-
tial cellular pathways such as ion/Ca2þ flux and cell viability
through apoptosis regulation.
2. GAAPs are Golgi ion channel proteins
2.1. GAAP ion channel activity, a core function
GAAP is predominantly a Golgi-resident protein [2]. This was
demonstrated first with anti-GAAP antibody and immuno-
electron microscopy [2] and then by expressing C-terminally
tagged GAAPs [2–4,7,8]. However, as GAAP concentration
increases during ectopic expression, hGAAP and vGAAPs also
become detectable in the ER, presumably as a result of overex-
pression and Golgi saturation [2]. With time, this accumulation
in the ER, a much larger organelle, is probably why GAAP
localization has also been reported in the ER [18,67,73].
vGAAPs from VACV and CMLV form ion channels that
are selective for cations [4]. This discovery remains the first
report of an ion channel encoded by poxviruses. Electrophysio-
logical characterization of single GAAP channels relied on
spontaneous opening of these channels consistent with sugges-
tions that the loss of Ca2þ from intracellular stores following
hGAAP or hBI-1 expression is due to passive leakage [6,23].
GAAPs and hBI-1 inhibit apoptosis, increase cell spreading
andmigration speed and reduce the Ca2þ content of intracellu-
lar stores. Whether these effects are independent or the result
of a common core function of these proteins is only now
becoming clearer. Mutagenesis showed that two important
biological effects of vGAAP, apoptosis and migration, are
separable. Residues E207 or E178 are important for cell migration
and adhesion but do not affect the ability of vGAAP to protect
cells from apoptosis. In contrast, D219 is required for the anti-
apoptotic activity of vGAAP but not cell migration and
adhesion, but both functions are susceptible to mutation of
the pore-associated residues E207 and D219 [4] (figure 2). This
suggests that the ion channel activity of GAAPsmay constitute
the core function from which cell adhesion, migration and
apoptotic protection are regulated. Consistent with the obser-
vations with GAAPs, mutation of the equivalent D219 residue
in hBI-1 (D213 in hBI-1) attenuates the ability of BI-1 to reduce
the Ca2þ content of the ER [51]. Furthermore, in the bacterial
BI-1 orthologue, BsYetJ, this residue forms part of salt bridges
that regulate pore opening upon protonation [52], suggesting
that Ca2þ regulation and channel activity in BI-1 are also
likely to be linked. However, the separation of major functions
such as inhibition of apoptosis and cell migration has not been
studied in BI-1. Despite having a topology that is broadly remi-
niscent of the a-subunits of eukaryotic voltage-gated channels
[74], GAAPs lack obvious signaturemotifs related to selectivity
or conductance [4]. This suggests that GAAPs may form chan-
nels with novel structures and may have a unique mechanism
of action.
2.2. Consequences of GAAP oligomerization
Many ion channels are oligomeric proteins and oligomeriza-
tion (homo or hetero) plays an important role in the
regulation of ion flux or channel conductance. Most TMBIM
proteins show several species with differing electrophoretic
mobility during SDS-PAGE suggesting that homo-oligomeriza-
tion is a conserved feature of this family [23,41,50]. Although a
pH-dependent regulation mechanism has been demonstrated
for multiple functions of BI-1, a pH-dependent mechanism for
GAAP activity remains elusive. However, the oligomerization
of vGAAP and hGAAP is dependent on pH, with a more alka-
line pH favouring oligomerization. This is contrary to basal
Golgi pH, which is more acidic than that of the ER. In the
lumen
cytosol
—
 channel conductance [4]
—
 ion selectivity [4]
—
 lining the pore
—
 cell spread and migration [4]
—
 cell spread and migration [4]
—
 component of BsYetJ
  putative channel-closing
  latch [52]
—
 channel conductance [4]
—
 lining the pore
—
 inhibition of apoptosis [4]
—
 component of BsYetJ
  putative channel-closing
  latch [52]
—
 anti-apoptotic activity [2]
—
 cell migration and spread [7]
—
 Ca2+ modulation [7]
E207
E178
R90 D196
D219
C-terminus (LEAVNKK)
N
C
proposed pore region
Figure 2. Diagram of GAAP highlighting regions/residues of importance for
its different functions.
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case of vGAAP, two cysteine residues responsible for direct
protein oligomerizationwere identified [8]. Using Fo¨rster reson-
ance energy transfer (FRET), it was shown that a vGAAP
double cysteine mutant (C9S/C60SvGAAP) was unable to oligo-
merize in native Golgi membranes of live cells. Although no
oligomerization was detectable by FRET, this mutant retained
its anti-apoptotic activity and its effect on intracellular Ca2þ
stores, proving that monomeric vGAAP is functional. There-
fore, a model where the oligomeric state provides an on–off
switch forGAAPactivity is highly unlikely. However, an altera-
tion of conductance or ion flux might be influenced by
oligomerization and this remains to be tested electrophysiologi-
cally using the monomeric GAAP mutant. Surprisingly, the
cysteine residues responsible for vGAAP oligomerization are
absent from hGAAP, suggesting a different oligomerization
mechanism for hGAAP that is independent of cysteines.
BI-1 and GAAP oligomerization are at least partially pH-
dependent. An acidification of the cytosol results in increased
oligomerization of BI-1, and BI-1-expressing cells show more
Ca2þ release from stores under acidic conditions, but there is
still no proof that the two are directly linked [23]. Amino acid
residues required for BI-1 oligomerization have not been
identified and so no monomeric BI-1 mutant is available to
test if oligomerization is essential for its ion channel function.
Although a BI-1 C-terminal peptide, which lacks all the
regions identified in hGAAP that are required for oligomeri-
zation, is able to conduct ions across a membrane [75], its
actual oligomeric state is unknown.
Interaction between different members of the TMBIM
family has been reported, namely between BI-1 and GRINA,
suggesting that a possible hetero-oligomerization of different
TMBIM members could be relevant for TMBIM activity or
regulation [41]. A limitation of this approach is the fact that
most protein–protein interaction data were obtained from co-
immunoprecipitation assays, and TMBIM proteins are highly
susceptible to co-precipitate with any membrane protein or
highly abundant proteins due to their high degree of hydro-
phobicity [4]. Even under very stringent conditions, it was
possible to co-precipitate GAAP with several membrane and
soluble proteins, some of which do not even localize at the
Golgi. Therefore, no convincing protein interactions have so
far been detected with any of the GAAPs. To address this
issue, more robust techniques such as FRET [76], protein com-
plementation assays [77] or two-hybrid assays [78] could be
used to investigate TMBIM protein–protein interactions.
2.3. GAAP topology is unique among mammalian and
viral ion channels
Owing to the highly hydrophobic nature of ion channels,
which makes them experimentally difficult proteins to work
with, the majority of channel structures have remained
unsolved. The first ion channel structure solved was the pro-
karyotic KcsA Kþ channel in 1998 [79], and thereafter ion
channel structure has been a rapidly growing field.
Structurally, the simplest of all known prokaryotic and
eukaryotic channels consists of two transmembrane segments
(2TM) (figure 3, green), separated by a selectivity filter and
pore-forming loop known as the P-region. This basic motif,
which is adopted for instance by the eukaryotic Kþ inward
rectifier (Kir) and the prokaryotic Kþ channel (KcsA), is
thought to form the basic building block fromwhich the diverse
other ion channel types have evolved [74,80,81]. This structure
has been expanded with the addition of four transmembrane
(TM) segments (figure 3, blue) to form the 6TM arrangement
(Kir, Kcv)
2TM
2*2TM
6TM+2TM 2*6TM
4*6TM
(TPC1)
(Cav, Nav, Rb21)
(GLU) (GAAP)(Kv, IP3R)(CeK)
(TOK1)
6TM 6TM
?
P
P
inverted 2TM+1TM
Figure 3. Current model of the structural phylogeny of voltage-gated Kþ channels – where does GAAP fit in? The presumed precursor (green) consists of two
transmembrane regions (2TM) separated by a pore-forming loop (P), which is common to all Kþ channels. This 2TM ancestor is expected to resemble the prokaryotic
Kir and the viral Kcv. Other ion channels are thought to have arisen from the combination of duplication events such as 2*2TM, and the addition of TMDs to the
minimal 2TM structure, such as 6TM. The pore-forming region (P) of GAAP is indicated in purple. Ion channel examples for the different types of structural motifs are
given. The dotted lines link the most closely related structures, thereby identifying the proposed structural precursors. IP3R, inositol 1,4,5-trisphosphate receptor.
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(named S1–S6) of most eukaryotic channels, such as voltage-
gated Kþ channels (Kv), and forms the structural basis for
Naþ and Ca2þ voltage-gated channels (Nav and Cav, respect-
ively) [80–82]. Typically, S4 contains the voltage sensor, while
S5–S6 contain the selectivity filter. Duplication and fusion
events using a combination of the 2TM precursor unit and the
6TM structure are thought to have therefore given rise to the
larger channel structures shown in figure 3.
Although the evolution of Kþ channels has been traced
back to the prokaryotic world as a 2TM structure, phyloge-
netic studies have usually excluded ion channels of viral
origin based on the assumption that viruses may have
acquired host genes by horizontal gene transfer [74,80]. How-
ever, phylogenomic evidence that some viral genes, including
viral Kþ channel-encoding genes, did not originate from their
hosts [83,84] has highlighted the importance of including
viral ion channels in these evolutionary analyses. This is par-
ticularly relevant to large algae-infecting viruses such as
chloroviruses, which lack aa similarity between viral and
host proteins or of close orthologues in databases, thus raising
the question of the true donor organism(s) of these genes
[83,84]. With the subsequent inclusion of viral Kþ channels in
these evolutionary studies, viral ion channels with the 2TM
configuration, such as the chlorella virus Kcv channel, have
been added to the list of progenitor-like channels (figure 3)
[85]. These chloroviruses-encoded Kþ channels have even
been hypothesized by phylogenetic analysis as the closest
channels to the evolutionary ancestor of all Kþ channel proteins
[85], consistent with evidence that some large DNA viruses
may have predated or coexisted with the last universal
common ancestor of bacteria, archaea and eukarya [86–88].
The first described viral ion channel is the M2 protein
from influenza virus A [89]. Since then, other ion channels
encoded by viruses have been discovered and are grouped
within a family of viral ion channels known as viroporins.
These are typically much shorter than cellular ion channels
encompassing between 50 and 120 aa and contain no more
than 1–3 TM regions that homo-oligomerize often into tetra-
mers, thus constituting minimalistic versions of ion channels
[90,91]. For instance, the 97 aaM2 protein contains a single TM
[92] that assembles into a homo-tetrameric Hþ-permeable pore
important for viral entry [93,94]. Once the virus is taken into
the endosome, acidification of the virion interior mediated by
M2 promotes virus uncoating and the release of viral RNA
into the host cell [95]. Another example is the 94 aa viral Kþ
channel, Kcv, from chlorella virus 1 (Paramecium bursaria
Chlorella virus 1, PBCV-1) that resembles the 2TM bacterial
channels Kir and KcsA [96,97]. The two putative TM regions
of Kcv are separated by a 44 aa pore region that contains the
TXXTXGFG signature pore sequence of Kþ channels [97].
PBCV-1 induces the rapid depolarization of the infected cells,
and this is believed to be the result of Kcv channel incorporation
into the host membrane and mediating Kþ efflux from the cell
[98]. Other examples of viral ion channels include Vpu from
human immunodeficiency virus-1, p7 from hepatitis C virus,
VP4 from poliovirus and 3a from severe acute respiratory
syndrome-associated coronavirus (SARS-CoV) (figure 4).
In contrast, the topology of GAAP is unlike any other
viral ion channel described hitherto and contains some key
differences with known eukaryotic or prokaryotic ion chan-
nels outside of the TMBIM/LFG family. GAAPs have short
inter-membrane loops ranging from 3 to 11 aa, with the lar-
gest membrane-free region being a short cytosolic tail of
approximately 35 aa at the N terminus [3,4]. Topology map-
ping, by the insertion of peptide epitopes into different inter-
TM loops or at the N or C terminus of GAAP, indicated that
GAAPs have both the N and C termini in the cytosol, 6 TMDs
and an additional C-terminal hydrophobic region or loop
(figures 1, 4 and 5) [3]. On the other hand, the high-resolution
structure of YetJ from Bacillus subtilis (BsYetJ), a bacterial
orthologue of hBI-1 and hGAAP (with about 20% aa identity)
interpreted to form a Hþ-regulated Ca2þ channel, revealed a
seventh TMD, located at the core of the structure [52]. The
origin of the difference in the apparent organization of this
hydrophobic region 7 between GAAPs and BsYetJ is not
clear. It is possible that attaching a tag such as the hemaggluti-
nin (HA) epitope, despite being short (9 aa), at the C terminus
of GAAPs induced an aberrant topology, although GAAP
tagged in this way retained its function as a regulator of apop-
tosis, adhesion, migration and Ca2þ homeostasis [3,4,7,8]. It is
also possible that the C terminus of GAAP is in equilibrium
between two states, one of which is favoured by the addition
cytosol
ER/Golgi lumen
M2 (IAV)
Vpu (HIV-1)
p7 (HCV)
6K (SV)
P3A (PV) P2B (PV) GAAP (VACV, CMLV)
N-terminus
class I
subclass A subclass B subclass A subclass B
class II class III
C-terminus
Figure 4. Topology-based classification of viroporins/viral ion channels. Class I viroporins contain proteins with a single transmembrane domain that are inserted
into the membrane with either a lumenal N terminus and cytosolic C terminus (class IA) or the reverse orientation (class IB). Class II viral pores contain two
transmembrane domains. Members of subclass A have lumenal N and C termini, whereas members of subclass B have cytosolic N and C termini. Examples of
known viroporins of each subclass are shown. An additional class (III) is proposed for viral pores containing 6–7 transmembrane domains, which do not fit
within the conventional classes I or II. HCV, hepatitis C virus; IAV, influenza A virus; HIV-1, human immunodeficiency virus 1; PV, poliovirus; SV, Sindbis virus;
Vpu, viral protein U.
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of a C-terminal tag and the other by the crystallization con-
ditions used to solve the structure of BsYetJ, a related highly
hydrophobic protein. Alternatively, there may be genuine
differences in the membrane topologies of GAAPs and the
distantly related hBI-1 bacterial protein.
The identification of vGAAP residues important for the pore
(E207 and D219), their conservation among distantly related
proteins and topological data suggest that the C-terminal hydro-
phobic loop probably lines the channel pore (figure 2) [4].
Therefore,GAAPsdiffer fromthe6TMconsensusofKþ channels,
inwhich thepore region is locatedbetweenTM5and6, in that the
pore region of GAAPs is shifted further towards the C terminus
(figure 3). Likewise, the crystal structure of BsYetJ is structurally
different to any known ion channel [52]. Even in terms of size,
237 aa and 6–7 TM regions, GAAP is approximately threefold
larger than that of any other viroporin (figure 4).
Considering that GAAP topology and the location of its
pore region does not fit well within the current structural con-
sensus of ion channel evolution, this suggests that GAAP may
have evolved from a modified branch of the 2TM Kir-like pre-
cursor unit or from a different precursor (figure 3). GAAPs
present a novel type or sub-type of ion channel structure,
unlike any known viroporin in size, structural complexity
and function (figures 3 and 4). Viral GAAP therefore represents
a novel class (type III) of viral channels (figure 4).
The majority of viroporins have been associated with viral
entry, assemblyor release [99] and serve as ideal anti-viral drug
targets. The same is true formanymammalian and prokaryotic
channels implicated in disease pathology. However, issues
relating to target specificity can often give rise to important
side-effects and acquired drug resistance, as seen, for instance,
with the M2-targeting compound amantadine [100,101]. Con-
sequently, more detailed electrophysiological, structural and
functional properties of channels are of particular value for
improved targeted drug development.
3. Why GAAPs confer such broad-ranging
protection against apoptotic stimuli
Considering that apoptotic regulators are mostly localized in
the cytosol, the ER or the mitochondria, the Golgi represents
an unconventional location within the cell from which to
regulate apoptosis. In an attempt to address whether Golgi
localization is required for its anti-apoptotic functions, a range
of mutations (single aa substitution, short sequence changes,
truncations and chimaeras) were introduced to alter GAAP
localization. However, this has only yielded inconclusive
results (unpublished data), probably reflecting the tight
interplay between protein structure and function.
When comparedwith other TMBIMmembers, GAAP is the
broadest anti-apoptotic inhibitor (table 1). Cells overexpressing
vGAAP or hGAAP and challenged with a variety of intrinsic
and extrinsic pro-apoptotic stimuli showed an increased resist-
ance to programmed cell death [2]. However, the mechanism
behind such a broad range of protection is unclear. Perhaps,
given the central role of Ca2þ in apoptosis, it is likely that
modulation of Ca2þ by GAAP plays a role in this process
[4,6,7]. The fact that GAAP overexpression reduces the Ca2þ
filling state of the ER and Golgi suggests that apoptosis protec-
tionmay derive from reduced release of Ca2þ from intracellular
stores upon pro-apoptotic stimuli, leading to a reduced entry of
Ca2þ in the mitochondria and thus delaying and hampering
apoptosis [6] (figure 5). The mechanism by which GAAP and
other TMBIM family members control apoptosis requires
further analysis and it is possible that the anti-apoptotic
activity of these proteins constitutes a secondary effect of
their regulation of Ca2þ.
4. GAAP-mediated regulation of cell
motility and adhesion
Several cellular processes are affected when TMBIM protein
expression is manipulated. In addition to protecting cells
from apoptotic stimuli and modulating the content of intra-
cellular Ca2þ stores, overexpression of vGAAP and hGAAP
increases cell migration, adhesion and spreading [4,7]. Store-
operated calcium entry (SOCE) is enhanced by hGAAPoverex-
pression and leads to greater activation of calpain 2 near the
plasma membrane (PM), probably by binding free Ca2þ enter-
ing the cell from the extracellular space [7] (figure 5). Active
calpain 2 accelerates the turnover of focal adhesions thereby
contributing to the observed increased cell migration, adhesion
and spreading phenotypes [7]. Conversely, the opposite
phenotype is observed upon hGAAP knock down [7].
The effects of GAAP on cell motility are consistent with the
described role of GAAP as a cation-selective channel [4]. When
a residue that affects the ion channel conductance (E207) of
vGAAP was mutated, the impact of protein overexpression
focal adhesion complex
focal adhesion disassembly
adhesion and motility
calpain 2
cell viability
Ca2+ Ca2+ Ca2+
Ca2+Golgi/ER
direction of migration
focal adhesion assembly
focal contact
substrate
Nucleus
apoptosis
SOCE
cytosolic[Ca2+]
Golgi/ER[Ca2+]
?
SOCE channelhGAAP
Figure 5. Summary model of the functional effects of GAAP in regulating intracellular ion flux, apoptosis, cell adhesion and migration. Modified from Saraiva et al. [7].
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on cell migrationwas lost, demonstrating the importance of the
ion channel activity for GAAP-induced cell migration [4].
The detailed mechanism by which GAAP stimulates
SOCE remains unclear. Considering the localization of
GAAP within the Golgi and its ability to modulate the Ca2þ
content of both the Golgi and the ER, several mechanisms are
possible: (i) the depletion of luminal Golgi Ca2þ may affect
the Ca2þ content of the ER and activate the typical SOCE path-
way involving Orai1 and stromal interaction molecule 1
(STIM1); (ii) GAAP induces an alteration in Orai1 and/or
STIM1 proteins; and (iii) GAAP within the Golgi contributes
directly to SOCE activation via an unknown Golgi SOCE
sensor(s). Positioning of the Golgi to the rear of the nucleus
has been proposed to be important in regulating polarization
and directed cell migration (reviewed in [102]). Whether or
not hGAAP participates in Golgi positioning and polarization
during cell migration by affecting the activation and/or local-
ization of calpain 2, SOCE-related proteins or by any other
mechanism is unknown.
Two other members of the TMBIM family (TMBIM6/BI-1
and TMBIM2/LFG) can also affect cellular mechanisms
involved in cell migration and adhesion. Interestingly,
increased expression of both BI-1 and LFG correlated with
increased metastasis [36,63]. BI-1 overexpression induces
cell migration by directly interacting with actin and by pro-
moting actin polymerization [25]. Like GAAP, BI-1 induces
SOCE, and this is dependent on the C-terminal lysine resi-
dues involved in actin binding [25], suggesting a possible
link with cytoskeletal remodelling.
In a neuroblastoma (NBL) cell model, LFG repression
resulted in reduced cell adhesion, increased sphere growth
and enhanced migration [36]. Similarly, LFG knockdown
increased the in vivo metastatic potential of SH-SY5Y and
altered the expression profiles of several genes involved in
cell adhesion and migration [36]. This supports a role for
TMBIM members as cell motility regulators and possibly as
players in tumour progression and metastasis.
5. Future perspectives
Despite much progress, it remains unclear whether the mul-
tiple functions of GAAP are linked or separate. The specific
inhibition of ion channel activity by pharmacological inhibi-
tion or by mutagenesis could provide an interesting tool to
dissect the mechanisms involved in each of GAAP’s described
functions. Data to date suggest that all GAAP-dependent func-
tions rely on its ion channel activity, but contributions from the
regulation of other Golgi ion channels or Golgi resident pro-
teins remain possible. Generation of a GAAP knockout
mouse (if viable) would shed some light on the important in
vivo functions of GAAP as well as possible interactions with
other TMBIM family members. All published TMBIM gene
knockoutmice are viable [41,47,103]. However, the importance
of GAAP for cell viability increases the likelihood of lethality
in vivo. Double TMBIM knockout mice lethality has also
been suggested due to possible complementary functions of
these proteins. Therefore, generation of conditional knockout
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Figure 6. Global dysregulation of hGAAP mRNA in cancers. The Oncomine cancer microarray database (http://www.oncomine.com) was used to assess the dysre-
gulation of hGAAP expression in several cancer tissues relative to healthy subjects. (a) Comparison of expression pattern between hGAAP and hBI-1. The table shows
the number of studies reporting mRNA fold change 1.5 relative to normal tissue, using a threshold p-value of 0.05. The colour code reflects the best gene
percentile (i.e. the top 1, 5 or 10% group of most altered genes). (b) Comparison of the frequency of hGAAP dysregulation between different cancer tissues.
Data show the percentage of cancers in which hGAAP mRNA is over-expressed (red) or under-expressed (blue) compared with normal tissue, using a dysregulation
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mice in future will help to dissect the role of GAAP in vivo in
homeostasis and disease models.
Although much is known about the roles of GAAP in the
cell, the exact role for GAAP during poxvirus infection remains
unclear. vGAAP expression by VACV strain Evans did not
affect virus replication or spread in cell culture but reduced
the virulence of this VACV strain following infection in mice
[2]. The infection with a virus lacking vGAAP was character-
ized by enhanced infiltration of leucocytes into the infected
tissue, showing that vGAAP is immunomodulatory. A com-
parison of four different anti-apoptotic proteins encoded by
VACV showed that, in comparison, vGAAP is not a potent
anti-apoptotic protein when expressed during viral infection,
making it unlikely that its anti-apoptotic activity explains
fully its effect on virulence [104].
TMBIM1, 2, 3 and 4 can all be found in Golgi membranes,
but most of their role(s) in this organelle remain elusive. Shed-
ding light on the processes inwhich these proteins are involved
could help to dissect and understand Golgi functions. One of
the central questions about the Golgi revolves around the
spatial organization of the signals arriving at and originating
from this organelle. How GAAP that is localized in the Golgi
can activate Ca2þ entry from the extracellular space that
occurs at the PM remains unclear. Golgi-originated stress sig-
nals and sensors involved in organelle-initiation of apoptosis
have been proposed to mediate this, but no specific protein
has been identified in this context thus far [105–107].
Given the fact that hGAAP can protect cells from apoptosis,
promote cell viability, and upregulate cell adhesion and
migration, it is possible that hGAAP has a role in tumour
progression. Cell hyper-proliferation within confined,
nutrient-poor environments triggers a variety of apoptotic
stresses, thus anti-apoptotic genes are important contribu-
tors of cancer progression. In addition, activation of SOCE,
calpain 2 activity, and alterations in the migration and
attachment capabilities of cancer cells to other cells or the
extracellular matrix are typical hallmarks of carcinoma
progression to higher-grade malignancies [108–110].
Significant upregulation of hGAAP mRNA has been
detected in brain and lung tumours. In glioblastoma multi-
forme, high hGAAP mRNA levels are associated with poor
outcome [43], and the dysregulation of hGAAP in non-small
cell lung carcinoma samples led to hGAAP being proposed
as a novel candidate prognostic marker for this disease in
non-smoking patients [44]. An analysis of currently available
microarray studies via the Oncomine platform indicates that
hGAAP is over-expressed (figure 6a), with greatest frequency
(figure 6b) in cancers of the brain and prostate, and under-
expressed with unusual frequency in colorectal cancers
(figure 6b). Unlike a previous report [18], this analysis
showed that the pattern of hGAAP dysregulation among
cancer tissues aligns with that of hBI-1, and this may become
clearer as more studies include both BI-1 and hGAAP probes.
BI-1 is also upregulated in some glioma [60] and lung cancers
[59,61], as well as prostate [58,62] and breast cancer [56,57].
FAIM2/LFG/TMBIM2 overexpression also correlates with
high primary breast tumours grades [38], and low LFG levels
correlate with poor overall survival of NBL patients [36].
As GAAP confers resistance to a wide range of apoptotic
stresses in vitro, including the anti-cancer drugs cisplatin and
doxorubicin [2], it would be important to determine whether
hGAAP correlates with resistance to chemotherapy and/or
with poor prognosis, and thus represents an important
indicator and therapeutic target.
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